0001104659-20-064448.txt : 20200520 0001104659-20-064448.hdr.sgml : 20200520 20200520215915 ACCESSION NUMBER: 0001104659-20-064448 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200409 FILED AS OF DATE: 20200520 DATE AS OF CHANGE: 20200520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant V Luxco S.a r.l. CENTRAL INDEX KEY: 0001786141 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 20899867 BUSINESS ADDRESS: STREET 1: 15, BOULEVARD F.W. RAIFFEISEN CITY: LUXEMBOURG STATE: N4 ZIP: L-2411 BUSINESS PHONE: (415) 801-8100 MAIL ADDRESS: STREET 1: 15, BOULEVARD F.W. RAIFFEISEN CITY: LUXEMBOURG STATE: N4 ZIP: L-2411 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Venture Capital V, L.P. CENTRAL INDEX KEY: 0001589097 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 20899868 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Affiliates Fund V, L.P. CENTRAL INDEX KEY: 0001589095 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 20899869 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Ophthalmic Affiliates I, L.P. CENTRAL INDEX KEY: 0001589098 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 20899870 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Venture Capital V (Canada), LP CENTRAL INDEX KEY: 0001612235 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 20899871 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Ventures V, LLC CENTRAL INDEX KEY: 0001619298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 20899872 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-2215 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Ventures V (Canada), L.P. CENTRAL INDEX KEY: 0001716490 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 20899873 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: (650) 843-5000 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aprea Therapeutics, Inc. CENTRAL INDEX KEY: 0001781983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6095104718 MAIL ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 4 1 a4.xml 4 X0306 4 2020-04-09 1 0001781983 Aprea Therapeutics, Inc. APRE 0001786141 Versant V Luxco S.a r.l. 15 BOULEVARD F.W. RAIFFEISEN 2411 LUXEMBOURG N4 L-2411 LUXEMBOURG 0 0 1 0 0001589097 Versant Venture Capital V, L.P. 15 BOULEVARD F.W. RAIFFEISEN 2411 LUXEMBOURG N4 L-2411 LUXEMBOURG 0 0 1 0 0001589095 Versant Affiliates Fund V, L.P. 15 BOULEVARD F.W. RAIFFEISEN 2411 LUXEMBOURG N4 L-2411 LUXEMBOURG 0 0 1 0 0001589098 Versant Ophthalmic Affiliates I, L.P. 15 BOULEVARD F.W. RAIFFEISEN 2411 LUXEMBOURG N4 L-2411 LUXEMBOURG 0 0 1 0 0001612235 Versant Venture Capital V (Canada), LP 15 BOULEVARD F.W. RAIFFEISEN 2411 LUXEMBOURG N4 L-2411 LUXEMBOURG 0 0 1 0 0001619298 Versant Ventures V, LLC 15 BOULEVARD F.W. RAIFFEISEN 2411 LUXEMBOURG N4 L-2411 LUXEMBOURG 0 0 1 0 0001716490 Versant Ventures V (Canada), L.P. 15 BOULEVARD F.W. RAIFFEISEN 2411 LUXEMBOURG N4 L-2411 LUXEMBOURG 0 0 1 0 Common Stock 2020-04-09 4 J 0 2519323 0 D 0 D Common Stock 2020-04-09 4 J 0 2210937 0 A 2210937 D Common Stock 2020-04-09 4 J 0 66506 0 A 66506 D Common Stock 2020-04-09 4 J 0 73617 0 A 73617 D Common Stock 2020-04-09 4 J 0 168263 0 A 168263 D Common Stock 2020-05-18 4 J 0 773805 0 D 1437132 D Common Stock 2020-05-18 4 J 0 23275 0 D 43231 D Common Stock 2020-05-18 4 J 0 25794 0 D 47823 D Common Stock 2020-05-18 4 J 0 58889 0 D 109374 D Common Stock 2020-05-18 4 J 0 16428 0 A 16428 D Common Stock 2020-05-18 4 J 0 16428 0 D 0 D Common Stock 2020-05-18 4 J 0 1178 0 A 1178 D Common Stock 2020-05-18 4 J 0 1178 0 D 0 D Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant V Luxco S.a.r.l. ("Luxco") to its shareholders without consideration. These Shares are directly held by Versant VI Luxco S.a.r.l. ("Luxco"). Luxco is majority owned by Versant Venture Capital V, L.P.("VVC V") and minority owned by Versant Ophthalmic Affiliates Fund I, L.P. ("VOA"), Versant Affiliates Fund V, L.P. ("VAF V" and together with VVC V and VOA, the "Versant Funds") and Versant Venture Capital V (Canada) LP ("VVC CAN"). Versant Ventures V, LLC ("VV V") is the general partner of each of the Versant Funds. Versant Ventures V GP-GP (Canada), Inc. ("VV V CAN GP") is the general partner of Versant Ventures V (Canada), L.P. ("VV V CAN"), which is the general partner of VVC CAN. Represents a change in the form of ownership of VVC V by virtue of receipt of shares in the pro-rata in-kind distribution of Common Stock by Luxco. These securities are held of record by VVC V. VV is the sole general partner of VVC V and may be deemed to have voting and investment power over the securities held by VVC V and as a result may be deemed to have beneficial ownership over such securities. VVC V disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein. Represents a change in the form of ownership of VAF V by virtue of receipt of shares in the pro-rata in-kind distribution of Common Stock by Luxco. These securities are held of record by VAF V. VV V is the sole general partner of VAF V and may be deemed to have voting and investment power over the securities held by VAF V and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial owners of such shares except to the extent of its pecuniary interest therein. Represents a change in the form of ownership of VOA by virtue of receipt of shares in the pro-rata in-kind distribution of Common Stock by Luxco. These securities are held of record by VOA. VV V is the sole general partner of VOA and may be deemed to have voting and investment power over the securities held by VOA and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial ownership of such shares except to the extent of its pecuniary interests therein. Represents a change in the form of ownership of VVC CAN by virtue of receipt of shares in the pro-rata in-kind distribution of Common Stock by Luxco. These securities are held of record by VVC CAN. VV V CAN GP is the sole general partner of "VV V CAN and VV V CAN is the sole general partner of VVC CAN. By virtue of such relationships, VV V CAN GP and VV V CAN may be deemed to have voting and investment power over the securities held by VVC CAN and as a result may be deemed to have beneficial ownership over such securities. VV V CAN disclaims beneficial ownership of the shares held by VVC CAN, except to the extent of its pecuniary interests therein. Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VVC V without consideration to its partners. Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VAF V without consideration to its partners. Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VOA without consideration to its partners. Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VVC CAN without consideration to its partners. Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by VVC V, VAF V and VOA. The shares are held by VV V. Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VV V without consideration to its members. Represents a change in the form of ownership of VV V CAN by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by VVC CAN. The shares are held by VV V CAN. Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VV V CAN without consideration to its partners. VERSANT V LUXCO S.A.R.L. By: /s/ Robin L. Praeger, Manager 2020-05-20 VERSANT VENTURE CAPITAL V, L.P. By: Versant Ventures V, LLC Its: General Partner By: /s/ Robin L. Praeger, Managing Director 2020-05-20 VERSANT AFFILIATES FUND V, L.P. By: Versant Ventures V, LLC Its: General Partner By: /s/ Robin L. Praeger, Managing Director 2020-05-20 VERSANT OPHTHALMIC AFFILIATES FUND I, L.P. By: Versant Ventures V, LLC Its: General Partner By: /s/ Robin L. Praeger, Managing Director 2020-05-20 VERSANT VENTURE CAPITAL V (CANADA) LP By: Versant Ventures V (Canada), L.P. Its: General Partner By: Versant Ventures V GP-GP (Canada), Inc. Its: General Partner By: /s/ Robin L. Praeger, Director 2020-05-20 VERSANT VENTURES V, LLC By: /s/ Robin L. Praeger, Managing Director 2020-05-20 VERSANT VENTURES V (CANADA), L.P. By: Versant Ventures V GP-GP (Canada), Inc. Its: General Partner By: /s/ Robin L. Praeger, Director 2020-05-20